In vitro pediculicidal and ovicidal activity of an extract and oil from fruits of Melia azedarach L. - 12/08/11
Córdoba, Argentina
Abstract |
Background |
Head louse infestation is difficult to control because of increasing lice resistance to synthetic pediculicidal drugs.
Objective |
To test the activity of extract and oil obtained from fruits of Melia azedarach L. against the head louse Pediculus humanus capitis.
Methods |
A filter paper diffusion bioassay was carried out in order to determine the pediculicidal and ovicidal activity of extract and oil from M azedarach L. fruits.
Results |
Both vegetable products, tested either individually or in combinations, showed high levels of mortality on adult lice, with values ranging between 62.9% and 96.5%. The highest mortality rate was obtained with a combination of 20% ripe fruit extract with 10% ripe fruit oil. A formulation made with both extract and oil at 10% plus the addition of emulsifier and preserving agents showed 92.3% pediculicidal activity. The products were also successful in delaying or inhibiting nymph emergence, with the formulation being the most effective, with a complete inhibition of emergence.
Limitations |
Because adult lice are sensitive to starvation and therefore control mortalities are often higher than 20% in tests with field specimens, the results may not reflect the direct effect of the extract.
Conclusions |
These results demonstrate the possibility of using Melia products for controlling head lice, which are difficult to control because of their resistance to the currently used anti-louse agents.
Le texte complet de cet article est disponible en PDF.Plan
Supported by a grant (no. 7124) from the Fund for Scientific Investigaion and Technology (Fondo para la Investigación Científica y Tecnológica; FONCyT). Conflicts of interest: None identified. Drs María C. Carpinella, Sara M. Palacios, and Walter R. Almirón are members of the National Research Council of Argentina (CONICET). |
Vol 56 - N° 2
P. 250-256 - février 2007 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?